Central

A Healthcare Company & subsidiary of API Holdings, PharmEasy, was all set for an IPO. Until it rolled back its plans, withdrawing its Draft Red Herring Prospectus (DRHP). Why did the company decide on it? What are the future plans? What does the growth trajectory look like? What is the story behind the Goldman Sachs […]